Join Myriad Oncology and Clarified Health as we partner together on a cutting-edge Molecular Tumor Board Series
We are excited to announce our continued partnership with Clarified Precision Medicine on the 2025 Molecular Tumor Board Series. Join our virtual tumor board to engage with leading cancer experts as they discuss the latest patient cases, utilizing combined germline and comprehensive tumor genomic profiling, to inform treatment decisions.
These Myriad Oncology Molecular Tumor Boards aim to bring together clinicians and their support staff to engage with leading cancer experts discussing 4 unique patient cases to interpret molecular findings to identify therapeutic decisions and outcomes.
Explore targeted therapies and management options for breast cancer patients based on germline and genomic findings.
Tuesday, September 30th from 5pm – 6pm EDT
Join Myriad Oncology and Clarified Health for our virtual Molecular Tumor Board on September 30th from 5pm-6pm EDT for an engaging discussion with leading cancer experts as they review the breast cancer patient cases.
Register now
Denise Yardley, MD
Breast Medical Oncologist SGE at the NCI Women’s Malignancies Branch Sarah Cannon Research Institute Nashville, TN
Derrick Haslem, MD
Senior Medical Director Oncology Clinical Program Intermountain Health St George, UT
Ben Kong, PharmD
Precision Medicine Specialist Knight Cancer Center Oregon Health Science University Portland, OR
Lincoln Nadauld, MD, PhD
GI Medical Oncology Intermountain Health St George, UT
Discover Myriad Oncology